Orchid Pharma rose 1.10% to Rs 723.50 after the company reported a 6.68% increase in consolidated net profit to Rs 23.78 crore for the fourth quarter ended March 2026, compared with Rs 22.29 crore in the corresponding quarter last year.
Market Samachar is a news aggregator. This article was originally published by Markets. Tap the button above to read the full story on their site.
Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.
1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.
Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.
Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.